Literature DB >> 9729616

Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons.

A I Sobolevsky1, S G Koshelev, B I Khodorov.   

Abstract

1. Using whole-cell patch-clamp techniques, the mechanisms of NMDA channel blockade by amino-adamantane derivatives (AADs) memantine (3, 5-dimethyl-aminoadamantane, MEM) and amantadine (1-aminoadamantane, AM) have been studied in rat hippocampal neurons acutely isolated by the vibrodissociation method. A rapid concentration-jump technique was used to replace superfusing solutions. 2. The aspartate (Asp)-induced channel opening greatly accelerated but was not a prerequisite for the recovery from the block by MEM: it was able to leave the channel without agonist assistance. The co-agonist (glycine) as well as the competitive NMDA antagonist DL-2-amino-7-phosphonoheptanoic acid (APV), did not affect this recovery. Membrane depolarization accelerated it, strongly suggesting that this process proceeded via the hydrophilic pathway of the channel. 3. A comparison of the kinetics of the recovery from the block by AADs in the presence and absence of the agonist prompted a hypothesis that the blocker trapped in the channel increased the probability of its transition to the open state. 4. Both MEM and AM were able to block NMDA channels not only in the presence but also in the absence of Asp, although in the latter case the effective blocking concentrations were much higher and the rate of the block development was much smaller than in the former case. The extent of the block increased with the duration of the blocker application. Glycine enhanced this block, while APV attenuated it. The MEM-induced blockade of agonist-unbound channels was enhanced by membrane hyperpolarization and weakened by external Mg2+. These findings strongly suggested that the blocker reached its binding sites via the same hydrophilic pathway both in the presence and absence of the agonist. 5. A comparative analysis of the channel unblocking kinetics in the presence of Asp after their blockade with or without the agonist assistance led us to conclude that in the two cases AADs were bound to the same blocking sites in the channel.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729616      PMCID: PMC2231181          DOI: 10.1111/j.1469-7793.1998.047bf.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  17 in total

1.  Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs.

Authors:  H Meguro; H Mori; K Araki; E Kushiya; T Kutsuwada; M Yamazaki; T Kumanishi; M Arakawa; K Sakimura; M Mishina
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

2.  Vibrodissociation of sliced mammalian nervous tissue.

Authors:  V S Vorobjev
Journal:  J Neurosci Methods       Date:  1991-07       Impact factor: 2.390

3.  Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels.

Authors:  J E Huettner; B P Bean
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction.

Authors:  B Hille
Journal:  J Gen Physiol       Date:  1977-04       Impact factor: 4.086

5.  Two blocking sites of amino-adamantane derivatives in open N-methyl-D-aspartate channels.

Authors:  A Sobolevsky; S Koshelev
Journal:  Biophys J       Date:  1998-03       Impact factor: 4.033

6.  A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones.

Authors:  M Benveniste; J Clements; L Vyklický; M L Mayer
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

7.  Heteromeric NMDA receptors: molecular and functional distinction of subtypes.

Authors:  H Monyer; R Sprengel; R Schoepfer; A Herb; M Higuchi; H Lomeli; N Burnashev; B Sakmann; P H Seeburg
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

8.  Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity.

Authors:  H S Chen; J W Pellegrini; S K Aggarwal; S Z Lei; S Warach; F E Jensen; S A Lipton
Journal:  J Neurosci       Date:  1992-11       Impact factor: 6.167

9.  The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurones in culture.

Authors:  P Ascher; L Nowak
Journal:  J Physiol       Date:  1988-05       Impact factor: 5.182

10.  Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones.

Authors:  J F MacDonald; M C Bartlett; I Mody; P Pahapill; J N Reynolds; M W Salter; J H Schneiderman; P S Pennefather
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

View more
  26 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

2.  Probing of NMDA channels with fast blockers.

Authors:  A I Sobolevsky; S G Koshelev; B I Khodorov
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.

Authors:  Shawn E Kotermanski; Jon W Johnson
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

4.  An NMDA receptor gating mechanism developed from MD simulations reveals molecular details underlying subunit-specific contributions.

Authors:  Jian Dai; Huan-Xiang Zhou
Journal:  Biophys J       Date:  2013-05-21       Impact factor: 4.033

5.  Effects of Mg2+ on recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site.

Authors:  Nathan G Glasgow; Madeleine R Wilcox; Jon W Johnson
Journal:  Neuropharmacology       Date:  2018-05-12       Impact factor: 5.250

6.  Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo.

Authors:  D Pubill; E Verdaguer; A M Canudas; F X Sureda; E Escubedo; J Camarasa; M Pallàs; A Camins
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

7.  Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization.

Authors:  Nathan G Glasgow; Nadezhda V Povysheva; Andrea M Azofeifa; Jon W Johnson
Journal:  J Neurosci       Date:  2017-09-06       Impact factor: 6.167

8.  Key binding interactions for memantine in the NMDA receptor.

Authors:  Walrati Limapichat; Wesley Y Yu; Emma Branigan; Henry A Lester; Dennis A Dougherty
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

Review 9.  Novel NMDA receptor modulators: an update.

Authors:  Rose M Santangelo; Timothy M Acker; Sommer S Zimmerman; Brooke M Katzman; Katie L Strong; Stephen F Traynelis; Dennis C Liotta
Journal:  Expert Opin Ther Pat       Date:  2012-09-26       Impact factor: 6.674

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.